Clinical Trial Update: Research Study in Patients With Advanced Ovarian Epithelial Cancer

View source ↗

Summary

A Gynecologic Oncology Group trial in advanced ovarian epithelial cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Serous Cystadenocarcinoma
• Ovarian Serous Surface Papillary Adenocarcinoma
• Stage Iiia Ovarian Cancer
• Stage Iiib Ovarian Cancer
• Stage Iiic Ovarian Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Serous Cystadenocarcinoma, Ovarian Serous Surface Papillary Adenocarcinoma | Status: WITHDRAWN